A novel medication, BYL719, demonstrates efficacy in treating CLOVES Syndrome by reducing vascular masses and improving quality of life. Patients show significant symptom reduction, growth stabilization, and improved overall health.
The Immunoscore test accurately predicts tumor recurrence risk in patients with colon cancer, enabling intensified treatment after surgery. The test identifies two types of immune cells in the tumor and its invasive margin, providing a reliable estimation of disease progression.
A recent study found that pregnant women infected with Zika virus experienced a significantly lower rate of congenital neurological abnormalities than initially thought. The study, which monitored over 2,000 women, revealed a 12.7% risk of complications when infected during the first trimester.
A study found that caffeine and its analogues restore memory deficits by addressing abnormal stress response mechanisms in the brain. Researchers normalized aging-like profiles in rats, reversing memory impairments linked to increased stress hormones.
Inserm has seen a 17.43% increase in publications in the top 68 journals rated by Nature, with contributions from researchers almost doubling in three years.
Researchers developed an antibody that prevents the immune system from attacking the myelin sheath, reducing demyelination and axon degeneration. In experimental mouse models, treatment with the antibody blocked progression of motor disorders and reduced lymphocyte infiltration into the nervous tissue.
The EPICE project highlights the underuse of effective medical practices, such as corticosteroid administration and surfactant therapy, in very premature infants. With improved care, mortality rates can be reduced by 18%, emphasizing the importance of evidence-based medicine for these high-risk babies.
A novel research program investigates the evolution of traumatic memories in individuals and collective memory after the Paris attacks. The study collects and analyzes testimonies from 1000 volunteers, with a focus on predicting post-traumatic stress disorder (PTSD) and recovery rates through biomedical markers.
Researchers suggest that anorexia nervosa is linked to the brain's reward system and a genetic factor involved in neuron survival. The study found that patients with anorexia nervosa experience increased sweating when viewing images of thin bodies, which may be related to the presence of a specific gene variant.
Researchers have synthesized a new drug, HA15, that reduces melanoma cell viability without being toxic to normal cells. This breakthrough discovery has the potential to improve treatment outcomes for patients with skin cancer.
MicroRNAs play a crucial role in controlling fertility and puberty by regulating the expression of gonadoliberin or GnRH, a neurohormone that stimulates sexual maturation. Failure to produce microRNAs leads to infertility and sterility in adults.
A group of 7 researchers from Europe and the US show that consensus exists around EDC definition and propose a logic-based approach similar to carcinogen identification. This guidance aims to resolve the 3-year blockage in publishing scientific criteria, allowing for efficient protection of public health.
Myotonic dystrophy causes wasting of skeletal muscles and arrhythmia due to mutated RNA sequences that alter gene regulation. Researchers identify altered SCN5A splicing as key factor in cardiac dysfunctions, paving way for potential treatment restoration of normal heart function.
Researchers from Inserm and Aix-Marseille University have confirmed that the ZIKA virus can be transmitted sexually. Genetic analysis showed a 100% correlation between the virus forms present in a man who contracted the virus in Brazil and a woman who had never traveled to an epidemic area but had sexual relations with him.
A new biotherapy has been developed to stimulate the creation of new lymphatic vessels in the heart, reducing oedema and inflammation. This innovative approach has shown significant promise in improving cardiac function following a myocardial infarction.
A study using transcranial magnetic stimulation found that temporarily inhibiting a specific brain region can alter the way people look at others. This technique offers new therapeutic possibilities for individuals with autism who often struggle to maintain eye contact.
A young patient infected with Zika virus presented with motor deficiency, intense pain, and urinary retention. Researchers detected high concentrations of the virus in cerebrospinal fluid and treated the patient with methylprednisolone, leading to improved neurological conditions.
A European alliance, EHVA, has been granted 28 million Euros to develop novel preventive and therapeutic vaccines against HIV. The project aims to accelerate the development of innovative HIV vaccine concepts, focusing on prophylactic and therapeutic approaches.
Inserm researchers identified early cellular changes in the brain that trigger depressive symptoms. They discovered a novel promising drug target, inhibiting protein phosphatase 2A, which rapidly ameliorates depression-like phenotypes in mice.
Inserm researchers have developed a noninvasive brain imaging method using MRI that provides the same information as physical palpation, allowing for early diagnosis of brain tumors or Alzheimer's disease. The technique uses noise correlation to detect natural shear waves in the brain, enabling building images of the brain's elasticity.
Researchers found that pre- and postnatal exposure to environmental tobacco smoke increases the risk of behavioral disorders in primary school children. Emotional disorders, such as anxiety and depression, are particularly affected, with 21% of children showing signs of emotional disorder after ETS exposure.
Scientists discovered that cannabinoid receptors in the brain exclusively control aversive memories, excluding neutral and positive ones. This finding has significant implications for treating diseases associated with emotional processes like depression and anxiety.
A biofilm with antimicrobial and anti-inflammatory properties has been developed to prevent or control post-operative infections on medical devices. The film reduces inflammation and prevents bacterial and fungal infections, offering a promising alternative to antibiotics.
Researchers have found that parasites resistant to artemisinin-based therapies can also resist other antimalarial drugs, making combination therapies less effective. This new multi-drug resistance is a serious threat to malaria treatments in Southeast Asia.
Researchers found a 30% increased risk of myeloblastic leukemia in children living within 150m of heavily used roads with combined road lengths over 260m. However, no association was observed for the more common lymphoblastic type of leukemia.
A new study reveals a direct relationship between Alzheimer's disease and brain cholesterol levels. Increasing the enzyme CYP46A1 may help eliminate excess cholesterol from the brain, correcting amyloid plaques and degenerated tau protein. This discovery opens up a new line of research for Alzheimer's treatment.
Scientists have elucidated a molecular mechanism that contributes to the 'cocktail effect' of endocrine disruptors when combined. The study shows that certain compounds bind cooperatively to a receptor in the cell nucleus, inducing a toxic effect at lower concentrations than individual molecules.
The study found that the 5-color nutritional labeling system is more effective than other systems in helping consumers understand food quality. This system, which uses a color-coded label to indicate nutrient content, was shown to increase the ability of individuals to rank foods by nutritional quality.
Researchers identified a new virus, AAV2, associated with rare liver cancer cases without cirrhosis or known risk factors. The virus targets genes involved in cell proliferation, leading to excessive expression and potentially favoring tumor development.
Researchers have discovered that cathelicidins, antimicrobial peptides produced by gut bacteria, play a crucial role in preventing the development of type 1 diabetes. By re-establishing a normal level of cathelicidin in diabetic mice, scientists were able to suppress autoimmune disease.
Researchers from INSERM have successfully induced totipotent cells, capable of producing an entire embryo and placenta, in collaboration with the Max Planck Institute. The team discovered that down-regulating a protein complex called CAF1 leads to chromatin reprogramming into a less condensed state.
A survey of 1,500 French general physicians found that while many are confident in vaccine benefits, concerns over adjuvants and controversy surrounding certain vaccines hinder recommendations. Trust in authorities is high, but training and resources are needed to address patient hesitancy.
A team of researchers has identified netrin-1 as a molecule that can favour the production of induced pluripotent stem cells, which have huge potential applications in regenerative medicine. The discovery may ultimately enable the creation of new organs from patient cells, eliminating rejection risks and ethical concerns.
A study combining clinical assessment, genomic analysis, and electroencephalography identified specific gene combinations in autistic patients that distinguished them from those with intellectual disabilities. This integrated approach provides new prospects for diagnosis and understanding of autism's physiological mechanisms.
Research from Inserm found a significant association between increased urinary levels of pyrethroid metabolites and decreased verbal comprehension and working memory in six-year-old children. The study suggests potential neurotoxic effects of pyrethroids on child development.
Researchers transformed bacteria into 'secret agents' that detect abnormal glucose levels in diabetic patients' urine. The bacteria are programmed using genetic transistors, allowing them to amplify and store molecular signals for months.
Researchers discovered IRF5 helps prevent metabolic complications by storing fat subcutaneously. In contrast to intra-abdominal fat, which leads to type 2 diabetes, this storage form reduces inflammation and promotes tissue remodelling.
Scientists have isolated dental stem cell lines and identified a natural mechanism for repairing tooth lesions. The study reveals that dopamine and serotonin play a crucial role in recruiting stem cells, which then repair the tooth. This breakthrough discovery opens up new therapeutic strategies to mobilize resident dental stem cells.
Researchers discover that blocking Slit2 protein prevents pathological blood vessel development in the retina, leading to a potential new treatment for vasoproliferative ocular diseases. The study suggests that therapies targeting Slit2 and its receptors may be beneficial for patients resistant to conventional anti-VEGF therapies.
Researchers have identified a new mechanism that controls glucagon secretion in humans, which could lead to more effective treatment of type 2 diabetes. By understanding this phenomenon, it is possible to elucidate the paradoxical effect of a new class of diabetes drugs and suggest modifications to this new type of treatment.
A team of researchers has created an organic electronic micropump that enables localised inhibition of epileptic seizure in brain tissue in vitro. The device attracts small positively charged molecules, projecting them toward the target area using electrical current.
Researchers discovered a genetic mutation causing a child's immune system dysfunction, leading to severe influenza. The study suggests that interferon amplification dependent on IRF7 expression is needed for protection against the virus.
Researchers from INSERM found that spironolactone, an antihypertensive drug, limits skin atrophy when used with corticosteroid-based creams. This study improves the efficacy and safety of corticosteroid-based dermatological treatments for inflammatory skin conditions.
A team of scientists has successfully repaired the damaged cerebral cortex of adult mice using cortical neurons derived from embryonic stem cells. The study suggests that only neurons of the same type as the damaged area can restore damaged circuits, providing new hope for treating brain injuries and diseases.
The JIKI clinical trial found encouraging signs of efficacy for favipiravir in individuals with high or moderate viral replication and less severe visceral lesions. In contrast, patients with very high viral loads and serious visceral involvement showed no efficacy from the treatment. These findings have implications for Ebola virus di...
Researchers from INSERM have demonstrated gallopamil's clinical efficacy in treating severe asthma by reducing bronchial smooth muscle mass and airway obstruction. The study involved 31 patients with severe asthma, who showed significant improvements in BSM thickness and asthma attacks after treatment.
The EPIPAGE 2 study found a significant improvement in the survival of premature infants in France, with survival rates increasing by 14% for infants born between 25-29 weeks. However, results for extremely premature infants show little progress, highlighting the need for better care and monitoring.
Researchers from Inserm confirm triheptanoin's efficacy in treating Huntington's disease by restoring normal brain energy metabolism. A pilot clinical trial with ten patients showed significant improvements, paving the way for a larger-scale trial.
Researchers have successfully developed a treatment that reduces the risk of skin graft rejection by combining interleukin 2 with rapamycin. The treatment has shown promising results in mice, with no signs of rejection observed after 30 days.
Researchers at INSERM have developed an innovative approach to produce human motor neurons from stem cells in just 14 days, nearly twice as fast as before. This breakthrough could lead to rapid progress in understanding and treating diseases like infantile spinal muscular amyotrophy and ALS.